Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10874616 Sustained-release dosage forms of ruxolitinib
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 28 Aug, 2024
"update inverses"
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12071439 Process and intermediates for preparing a JAK inhibitor
0
Edits on 22 Feb, 2024
"update inverses"
Golden AI
edited on 22 Feb, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11905292 Process and intermediates for preparing a JAK inhibitor
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms
0
Edits on 7 Sep, 2023
"update inverses"
Golden AI
edited on 7 Sep, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11744832 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
Edits on 22 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10874616
0
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 24 Apr, 2023
Infobox
Patent Citations Received
US Patent 11331320 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
0
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 24 Apr, 2023
Infobox
Patent Citations
US Patent 10166191 Sustained-release dosage forms of ruxolitinib
0
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 28 Mar, 2023
Infobox
Patent Citations Received
US Patent 11045421 Sustained release dosage forms for a JAK1 inhibitor
0
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 28 Mar, 2023
Infobox
Patent Citations Received
US Patent 11576864 Sustained-release dosage forms of ruxolitinib
0
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 26 Mar, 2023
Infobox
Patent Citations Received
US Patent 11337927 Sustained-release dosage forms of ruxolitinib
0
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 22 Mar, 2023
Infobox
Patent Citations Received
US Patent 11576865 Sustained-release dosage forms of ruxolitinib
0
"Entity importer update"
Golden AI
edited on 22 Mar, 2023
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10874616
0
Date of Patent
December 29, 2020
0
Patent Application Number
16190883
0
Date Filed
November 14, 2018
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10874616
0
Patent Citations
US Patent 10166191 Sustained-release dosage forms of ruxolitinib
0
Patent Citations Received
US Patent 11045421 Sustained release dosage forms for a JAK1 inhibitor
0
US Patent 11285140 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
0
US Patent 11331320 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
0
US Patent 11337927 Sustained-release dosage forms of ruxolitinib
0
US Patent 11576864 Sustained-release dosage forms of ruxolitinib
0
US Patent 11576865 Sustained-release dosage forms of ruxolitinib
0
Patent Primary Examiner
Umamaheswari Ramachandran
0
Edits on 15 Feb, 2023
"update inverses"
Golden AI
edited on 15 Feb, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11576865 Sustained-release dosage forms of ruxolitinib
0
"update inverses"
Golden AI
edited on 15 Feb, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11576864 Sustained-release dosage forms of ruxolitinib
0
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations Received
US Patent 11045421 Sustained release dosage forms for a JAK1 inhibitor
0
"update citations for inverse infoboxes"
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations
US Patent 10166191 Sustained-release dosage forms of ruxolitinib
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10874616
Edits on 25 May, 2022
"update inverses"
Golden AI
edited on 25 May, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent citations received
US Patent 11337927 Sustained-release dosage forms of ruxolitinib
Edits on 18 May, 2022
"update inverses"
Golden AI
edited on 18 May, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent citations received
US Patent 11331320 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
Edits on 30 Mar, 2022
"update inverses"
Golden AI
edited on 30 Mar, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent citations received
US Patent 11285140 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Load more
Find more entities like US Patent 10874616 Sustained-release dosage forms of ruxolitinib
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE